We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Urinary Tract Infection Tracked by Routine and Automated Urinalysis

By LabMedica International staff writers
Posted on 13 Sep 2016
Print article
Image: The UF-1000i fully automated urine particle analyzer (Photo courtesy of Sysmex Corporation).
Image: The UF-1000i fully automated urine particle analyzer (Photo courtesy of Sysmex Corporation).
Urinary tract infections (UTIs) are frequently encountered and the diagnosis of UTI using urine dipstick, Gram stain, urine culture often lack proven accuracy and precision in the emergency department (ED).

Because of its swiftness and low cost, urine dipstick (UD) is a commonly used test at the ED, but diagnostic accuracy is, however, based on primary care settings and therefore not compatible with the ED. UTI is confirmed by results of urine cultures (UCs), which are labor intensive, time consuming, and not available within the time frame of an ED visit.

Scientists at the University Medical Center Groningen (The Netherlands) analyzed a total of 381 cases presenting with fever and/or clinically suspected UTI. The following specific symptoms for UTI were determined: dysuria, pollakisuria, urinary urgency, hematuria, and back pain/lower abdominal pain. In addition, specific symptoms of UTI were determined: fever, chills, malaise, flank or perineal pain, and delirium.

For Gram staining, 10 μL of uncentrifuged urine was used. The color (gram negative or gram positive); shape (rods or cocci); and number of leukocytes, erythrocytes, and bacteria per high-power field (hpf) were determined semi-quantitatively at 100 × 10 magnification. The automated stick reader cobas u 411 was used with the UD Combur10 test (Roche Diagnostics, Mannheim, Germany). For UC, 1 μL of urine was inoculated on two agars (sheep blood agar and MacConkey3 agar) and incubated at 35°C for 16-20 hours in ambient air. Isolated organisms were measured semi-quantitatively as number of colony-forming units (CFU) per milliliter. For automated urine particle analysis, the team used the Sysmex UF-1000i (Sysmex Corporation, Kobe, Japan) is a fully automated urine particle analyzer based on flow cytometry.

The scientists reported 143 (37.5%) cases were diagnosed with UTI. Sensitivity of urine dipstick nitrite was 32.9% and specificity was 93.7%. Sensitivity of urine dipstick leukocyte esterase (3+) was 80.4% and specificity was 82.8%. Of the 143 cases with a UTI, 91 had a noninvasive UTI, 16 had a urosepsis confirmed by blood culture, 24 had a urosepsis based on clinical presentation, 11 had a pyelonephritis, and one had a prostatitis. Receiver operating characteristic curves of automated bacterial and leukocyte count showed area under the curve of 0.851 and 0.872, respectively. Cutoff values of 133 bacteria/μL and 48 leukocytes/μL resulted in a greater than 90% sensitivity.

The authors concluded that that in an unselected patient group presenting to the ED with suspected UTI, automated urine particle analysis with counts of leukocytes and bacteria results in comparable diagnostic accuracy compared with standard dipstick analysis but can slightly improve diagnostic accuracy, especially to make UTI unlikely, when added to standard clinical and UD analysis. The study was published in the August 2016 issue of the American Journal of Emergency Medicine.

Related Links:
University Medical Center Groningen
Roche Diagnostics
Sysmex Corporation
New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Molecular Diagnostics

view channel
Image: The HelioLiver Dx test has met the coprimary and secondary study endpoints in the CLiMB trial (Photo courtesy of Helio Genomics)

Blood-Based Test Outperforms Ultrasound in Early Liver Cancer Detection

Patients with liver cirrhosis and chronic hepatitis B are at a higher risk for developing hepatocellular carcinoma (HCC), the most prevalent type of liver cancer. The American Association for the Study... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Microbiology

view channel
Image: The POC PCR test shortens time for STI test results (Photo courtesy of Visby Medical)

POC STI Test Shortens Time from ED Arrival to Test Results

In a 2024 sexually transmitted infections (STIs) surveillance report by the World Health Organization (WHO), over 2.5 million cases were recorded, alongside a rise in the inappropriate use of antibiotics... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
LGC Clinical Diagnostics